Article
A pilot study on the use of cerebrospinal fluid cell-free DNA in intramedullary spinal ependymoma.
Journal of neuro-oncology - 1 Oct 2017
Connolly Ian David, Li Yingmei, Pan Wenying, Johnson Eli, You Linya, Vogel Hannes, Ratliff John, Hayden Gephart Melanie
Abstract excerpt
Cerebrospinal fluid (CSF) represents a promising source of cell-free DNA (cfDNA) for tumors of the central nervous system. A CSF-based liquid biopsy may obviate the need for riskier tissue biopsies and serve as a means for monitoring tumor recurrence or response to therapy. Spinal ependymomas most commonly occur in adults, and aggressive resection must be delicately balanced with the risk of injury to adjacent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
